News
NSF-funded Smartphone COVID-19 Diagnostic Test Could Put Testing in the Hands of the Public
A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for individuals to go to a healthcare facility. A prototype may be ready within two...
Press Releases
Sterling Pharma Solutions commence the production of potential COVID-19 treatment
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
Sterling will be manufacturing the active pharmaceutical ingredient (API) with the finished product being manufactured and supplied...
Press Releases
Abbott Earns Emergency Use Authorization for Another COVID-19 Antibody Test
Abbott Laboratories has won Emergency Use Authorization for another COVID-19-related diagnostics test for antibodies. This morning, the company said the U.S. Food and Drug Administration approved its SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system.
With the...
Clinical Trials
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval from India’s drug regulator DCGI in late April. Glenmark is the first company in...
News
Oliver Healthcare Packaging clinches Packaging Design of the Year Award
Singapore’s Oliver Healthcare Packaging received the Packaging Design of the Year Award at the recently concluded Healthcare Asia Pharma Awards 2020.
The award recognised the company’s proprietary Autoclavable Dispos-a-vent® Barrier Pouch, which provides medical device manufacturers a pouch option for...
Press Releases
INOVIO Expands Manufacturing of COVID-19 DNAVaccine INO-4800 With New Funding from CEPI
INOVIO announced it has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH & Co. KG, to support large-scale manufacturing of INOVIO's investigational DNA vaccine INO-4800, which currently is in Phase...
News
Massachusetts Hospital to Assess Mallinckrodt’s Nitric Oxide Treatment for COVID-19
Mallinckrodt and Massachusetts General Hospital teamed up to evaluate the potential benefits of inhaled nitric oxide as a treatment for pulmonary complications in patients infected with COVID-19.
The partnership will assess the benefit of INOmax (nitric oxide) gas in mechanically...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read